BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22537675)

  • 1. Complex rearrangement involving 9p deletion and duplication in a syndromic patient: genotype/phenotype correlation and review of the literature.
    Recalcati MP; Bellini M; Norsa L; Ballarati L; Caselli R; Russo S; Larizza L; Giardino D
    Gene; 2012 Jul; 502(1):40-5. PubMed ID: 22537675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome breakage hotspots and delineation of the critical region for the 9p-deletion syndrome.
    Christ LA; Crowe CA; Micale MA; Conroy JM; Schwartz S
    Am J Hum Genet; 1999 Nov; 65(5):1387-95. PubMed ID: 10521304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternally inherited partial monosomy 9p (pter → p24.1) and partial trisomy 20p (pter → p12.1) characterized by microarray comparative genomic hybridization.
    Freitas ÉL; Gribble SM; Simioni M; Vieira TP; Silva-Grecco RL; Balarin MA; Prigmore E; Krepischi-Santos AC; Rosenberg C; Szuhai K; van Haeringen A; Carter NP; Gil-da-Silva-Lopes VL
    Am J Med Genet A; 2011 Nov; 155A(11):2754-61. PubMed ID: 21948691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of the critical genomic region for congenital hyperinsulinism in the Chromosome 9p deletion syndrome.
    Banerjee I; Senniappan S; Laver TW; Caswell R; Zenker M; Mohnike K; Cheetham T; Wakeling MN; Ismail D; Lennerz B; Splitt M; Berberoğlu M; Empting S; Wabitsch M; Pötzsch S; Shah P; Siklar Z; Verge CF; Weedon MN; Ellard S; Hussain K; Flanagan SE
    Wellcome Open Res; 2019; 4():149. PubMed ID: 32832699
    [No Abstract]   [Full Text] [Related]  

  • 5. A Rare Case of Mosaic 3pter and 5pter Deletion-Duplication with Autism Spectrum Disorder and Dyskinesia.
    Bajracharya L; Lall M; Bijarnia-Mahay S; Kumar P; Mushtaq I; Saviour P; Paliwal P; Joshi A; Agarwal S; Suman P
    Case Rep Genet; 2023; 2023():7974886. PubMed ID: 37876589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel phenotype of 5p13.3-q11.2 duplication resulting from supernumerary marker chromosome 5: implications for management and genetic counseling.
    Armstrong ME; Weaver DD; Lah MD; Vance GH; Landis BJ; Ware SM; Helm BM
    Mol Cytogenet; 2018; 11():23. PubMed ID: 29599822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplication 9p and their implication to phenotype.
    Guilherme RS; Meloni VA; Perez AB; Pilla AL; de Ramos MA; Dantas AG; Takeno SS; Kulikowski LD; Melaragno MI
    BMC Med Genet; 2014 Dec; 15():142. PubMed ID: 25526829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another rare case of a child with de novo terminal 9p deletion and co-existing interstitial 9p duplication: clinical findings and molecular cytogenetic study by array-CGH.
    Kowalczyk M; Tomaszewska A; Podbioł-Palenta A; Constantinou M; Wawrzkiewicz-Witkowska A; Kowalski J; Kałużewski B; Zajączek S; Srebniak MI
    Cytogenet Genome Res; 2013; 139(1):9-16. PubMed ID: 22965227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic expansion of the interstitial 16p13.3 duplication: a case report and review of the literature.
    Li Z; Liu J; Li H; Peng Y; Lv W; Long Z; Liang D; Wu L
    Gene; 2013 Dec; 531(2):502-5. PubMed ID: 24035902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a complex rearrangement involving duplication and deletion of 9p in an infant with craniofacial dysmorphism and cardiac anomalies.
    Di Bartolo DL; El Naggar M; Owen R; Sahoo T; Gilbert F; Pulijaal VR; Mathew S
    Mol Cytogenet; 2012 Jul; 5(1):31. PubMed ID: 22768875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient with terminal 9 Mb deletion of chromosome 9p: refining the critical region for 9p monosomy syndrome with trigonocephaly.
    Mitsui N; Shimizu K; Nishimoto H; Mochizuki H; Iida M; Ohashi H
    Congenit Anom (Kyoto); 2013 Mar; 53(1):49-53. PubMed ID: 23480358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure 9p duplication syndrome with aplasia of the middle phalanges of the fifth fingers.
    Sato A; Suzuki T; Ikeno M; Takeda J; Yamamoto Y; Shinohara M; Makino S; Takeda S; Shimizu T; Itakura A
    Eur J Med Genet; 2020 Oct; 63(10):104005. PubMed ID: 32693209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome.
    Renard D; Taieb G; Garibaldi M; Maues De Paula A; Bernard R; Lagha N; Cristofari G; Vovan C; Chaix C; Lévy N; Khau Van Kien P; Sacconi S
    Am J Med Genet A; 2018 Aug; 176(8):1760-1763. PubMed ID: 30055030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature.
    Canton AP; Nishi MY; Furuya TK; Roela RA; Jorge AA
    Am J Med Genet A; 2016 Apr; 170A(4):1046-9. PubMed ID: 26689153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.
    Lemmers RJ; van den Boogaard ML; van der Vliet PJ; Donlin-Smith CM; Nations SP; Ruivenkamp CA; Heard P; Bakker B; Tapscott S; Cody JD; Tawil R; van der Maarel SM
    Hum Mutat; 2015 Jul; 36(7):679-83. PubMed ID: 25820463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trisomy 9p. A brief clinical, diagnostic and therapeutic description.
    Cammarata-Scalisi F
    Arch Argent Pediatr; 2019 Oct; 117(5):e473-e476. PubMed ID: 31560494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Duplication of Chromosome 9p in a Female Infant: Phenotype and Genotype Correlation.
    Leone PE; Pérez-Villa A; Yumiceba V; Hernández MÁ; García-Cárdenas JM; Armendáriz-Castillo I; Guerrero S; Guevara-Ramírez P; López-Cortés A; Zambrano AK; García JL; Hernández JM; Paz-Y-Miño C
    J Pediatr Genet; 2020 Mar; 9(1):69-75. PubMed ID: 31976149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 9p terminal deletion in nine Egyptian patients and narrowing of the critical region for trigonocephaly.
    Mohamed AM; Kamel AK; Eid MM; Eid OM; Mekkawy M; Hussein SH; Zaki MS; Esmail S; Afifi HH; El-Kamah GY; Otaify GA; El-Awady HA; Elaidy A; Essa MY; El-Ruby M; Ashaat EA; Hammad SA; Mazen I; Abdel-Salam GMH; Aglan M; Temtamy S
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1829. PubMed ID: 34609792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Cardiac Phenotype in 9p Deletion Syndrome: A Multicenter Italian Experience and Literature Review.
    Pugnaloni F; Onesimo R; Blandino R; Putotto C; Versacci P; Delogu AB; Leoni C; Trevisan V; Croci I; Calì F; Digilio MC; Zampino G; Marino B; Calcagni G
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From karyotypes to precision genomics in 9p deletion and duplication syndromes.
    Sams EI; Ng JK; Tate V; Claire Hou YC; Cao Y; Antonacci-Fulton L; Belhassan K; Neidich J; Mitra RD; Cole FS; Dickson P; Milbrandt J; Turner TN
    HGG Adv; 2022 Jan; 3(1):100081. PubMed ID: 35047865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.